142 related articles for article (PubMed ID: 17522431)
1. Prediction of lung cancer using volatile biomarkers in breath.
Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
[TBL] [Abstract][Full Text] [Related]
2. Enhancing diagnosis of benign lesions and lung cancer through ensemble text and breath analysis: a retrospective cohort study.
Wang H; Wu Y; Sun M; Cui X
Sci Rep; 2024 Apr; 14(1):8731. PubMed ID: 38627587
[TBL] [Abstract][Full Text] [Related]
3. A combined screening study for evaluating the potential of exhaled acetone, isoprene, and nitric oxide as biomarkers of lung cancer.
Wang H; Wei X; Wu Y; Zhang B; Chen Q; Fu W; Sun M; Li H
RSC Adv; 2023 Oct; 13(45):31835-31843. PubMed ID: 37908654
[No Abstract] [Full Text] [Related]
4. Breath Analysis for Lung Cancer Early Detection-A Clinical Study.
Jia Z; Thavasi V; Venkatesan T; Lee P
Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132879
[TBL] [Abstract][Full Text] [Related]
5. Ab initio investigation of functionalization of titanium carbide Ti
Alfalasi W; Hussain T; Tit N
Sci Rep; 2024 Jan; 14(1):1403. PubMed ID: 38228686
[TBL] [Abstract][Full Text] [Related]
6. An expanded risk prediction model for lung cancer.
Spitz MR; Etzel CJ; Dong Q; Amos CI; Wei Q; Wu X; Hong WK
Cancer Prev Res (Phila); 2008 Sep; 1(4):250-4. PubMed ID: 19138968
[TBL] [Abstract][Full Text] [Related]
7. A detection model for cognitive dysfunction based on volatile organic compounds from a large Chinese community cohort.
Jiao B; Zhang S; Bei Y; Bu G; Yuan L; Zhu Y; Yang Q; Xu T; Zhou L; Liu Q; Ouyang Z; Yang X; Feng Y; Tang B; Chen H; Shen L
Alzheimers Dement; 2023 Nov; 19(11):4852-4862. PubMed ID: 37032600
[TBL] [Abstract][Full Text] [Related]
8. The Detection of Colorectal Cancer through Machine Learning-Based Breath Sensor Analysis.
Poļaka I; Mežmale L; Anarkulova L; Kononova E; Vilkoite I; Veliks V; Ļeščinska AM; Stonāns I; Pčolkins A; Tolmanis I; Shani G; Haick H; Mitrovics J; Glöckler J; Mizaikoff B; Leja M
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958251
[TBL] [Abstract][Full Text] [Related]
9. Developing technologies and areas of interest in lung cancer screening adjuncts.
Park JA; Pham D; Yalamanchili S; Twardus S; Suzuki K
J Thorac Dis; 2024 Feb; 16(2):1552-1564. PubMed ID: 38505010
[TBL] [Abstract][Full Text] [Related]
10. Identification of volatile biomarkers for lung cancer from different histological sources: A comprehensive study.
Lv W; Shi W; Zhang Z; Ru L; Feng W; Tang H; Wang X
Anal Biochem; 2024 Jul; 690():115527. PubMed ID: 38565333
[TBL] [Abstract][Full Text] [Related]
11. Performance of empirical and model-based classifiers for detecting sucrase-isomaltase inhibition using the
Van Wyk H; Lee GO; Schillinger RJ; Edwards CA; Morrison DJ; Brouwer AF
medRxiv; 2024 May; ():. PubMed ID: 38746107
[TBL] [Abstract][Full Text] [Related]
12. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer biomarkers in exhaled breath.
Amann A; Corradi M; Mazzone P; Mutti A
Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath analysis for lung cancer.
Dent AG; Sutedja TG; Zimmerman PV
J Thorac Dis; 2013 Oct; 5 Suppl 5(Suppl 5):S540-50. PubMed ID: 24163746
[TBL] [Abstract][Full Text] [Related]
15. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
[TBL] [Abstract][Full Text] [Related]
16. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
17. Volatile organic compounds in exhaled air from patients with lung cancer.
Gordon SM; Szidon JP; Krotoszynski BK; Gibbons RD; O'Neill HJ
Clin Chem; 1985 Aug; 31(8):1278-82. PubMed ID: 4017231
[TBL] [Abstract][Full Text] [Related]
18. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
19. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
[TBL] [Abstract][Full Text] [Related]
20. Breath gas aldehydes as biomarkers of lung cancer.
Fuchs P; Loeseken C; Schubert JK; Miekisch W
Int J Cancer; 2010 Jun; 126(11):2663-70. PubMed ID: 19839051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
